0001209191-20-047504.txt : 20200819
0001209191-20-047504.hdr.sgml : 20200819
20200819163546
ACCESSION NUMBER: 0001209191-20-047504
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200817
FILED AS OF DATE: 20200819
DATE AS OF CHANGE: 20200819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Olson Eric R
CENTRAL INDEX KEY: 0001678149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37813
FILM NUMBER: 201117459
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001556263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453772460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-744-1340
MAIL ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: LS22, Inc.
DATE OF NAME CHANGE: 20120815
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-17
0
0001556263
Syros Pharmaceuticals, Inc.
SYRS
0001678149
Olson Eric R
C/O SYROS PHARMACEUTICALS, INC.
35 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
0
1
0
0
Chief Scientific Officer
Common Stock
2020-08-17
4
M
0
4963
1.01
A
4963
D
Common Stock
2020-08-17
4
S
0
4963
13.00
D
0
D
Common Stock
2020-08-18
4
M
0
10787
1.01
A
10787
D
Common Stock
2020-08-18
4
S
0
10787
13.00
D
0
D
Stock Option (right to buy)
1.01
2020-08-17
4
M
0
4963
0.00
D
2023-05-22
Common Stock
4963
105112
D
Stock Option (right to buy)
1.01
2020-08-18
4
M
0
10787
0.00
D
2023-05-22
Common Stock
10787
94325
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This option is fully vested.
/s/ Gerald E. Quirk, as attorney-in-fact
2020-08-19